Kuwait – Oct 2025

Pharma Intelligence Consultancy (PIC) is proud to announce its strategic partnership with NORSK Pharma, a leading Norway-based pharmaceutical manufacturer, reinforcing its mission to provide high-quality healthcare solutions across the GCC.

As the authorized representative of NORSK Pharma in Saudi Arabia, the UAE, Kuwait, Oman, and Bahrain, PIC will facilitate the introduction of innovative Norwegian pharmaceutical products to hospitals, healthcare providers, and distributors throughout the region.

This collaboration highlights PIC’s commitment to bridging global pharmaceutical innovation with regional healthcare needs. NORSK Pharma’s strong reputation for research-driven development, strict quality standards, and patient-focused solutions aligns seamlessly with PIC’s dedication to regulatory compliance, ethical partnerships, and sustainable market growth.

“Partnering with NORSK Pharma allows us to bring world-class Norwegian pharmaceutical products to the GCC, enhancing healthcare accessibility and patient outcomes,” Dr. Nedal Zeidan said from Pharma Intelligence Consultancy.

Through this partnership, PIC will oversee market entry strategies, product registration, and distribution planning, ensuring that NORSK Pharma’s portfolio is available and accessible to healthcare providers across the Gulf region.

• About NORSK Pharma: Headquartered in Norway, NORSK Pharma develops and manufactures premium pharmaceutical products that adhere to the highest European standards. Known for its advanced formulations and dedication to patient safety, NORSK Pharma combines scientific innovation with quality manufacturing.  https://www.norskpharma.no/en/home 

• About Pharma Intelligence Consultancy: Based in Kuwait, Pharma Intelligence Consultancy is a leading GCC-based pharmaceutical and healthcare consultancy firm, specializing in sales development, market expansion, regulatory consulting, acquisitions, and training. PIC connects global pharmaceutical expertise with local market knowledge to support sustainable healthcare growth.